Narcan is an opioid antagonist, making it a type of medicine that can rapidly reverse an opioid overdose. According to the FDA, in the 12 months ending in October 2022, there have been 101,750 overdose deaths in the US. In 2021, opioids were involved in 91% of drug overdose deaths. FDAs approval of this over the counter medicine is significant, and could potentially pave the way for more life-saving over the counter medicines to be sold.
The FDA first approved Narcan nasal spray in 2015 as a prescription drug. In February 2023, FDA Committee members voted unanimously to recommend it be approved for over-the-counter use.
The price of the nasal spray has not yet been released, but overdose protection agencies caution that the price may be too high for accessibility. The National Harm Reduction Coalition has expressed the need for Naloxone to be free so that everyone can have access to the life saving medication.
One way to possibly reduce the price of the nasal spray, which is expected to be around $47.50 a box, is placing a price ceiling on the product so retailers cant sell narcan for extremely high prices. But even though this could create more affordability for the product, it can also create a shortage, like how we learned in class.
Lastly, it is unclear when the naloxone nasal spray will be available to purchase everywhere without prescription. EmergentBioSolutions (narcan producers), say they hope to make the medication available to buy by late summer. Once Narcan medication can be sold everywhere with easy access, there could be a drastic reduction in the number of opioid-overdose related deaths
Sources:
https://nida.nih.gov/publications/drugfacts/naloxone
https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray
https://www.npr.org/2023/03/29/1166750095/narcan-fda-approval-naloxone-over-the-counter-otc
https://www.nytimes.com/2023/03/28/health/narcan-otc-price.html
https://www.mountainside-medical.com/products/narcan-nasal-spray-4mg-2-doses




